NSC5844

Research use only, not for human use.

NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.

NSC5844, also known as RE640, is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.

NSC5844 (Compound 10) is a 4-aminoquinoline derivative, and has antitumor activity with GI50s of 7.35 ± 0.10 μM and 14.80 ± 0.35 μM against MDA-MB-468 and MCF-7 cells, respectively. NSC5844 (Compound 1) is cytotoxic to P. falciparum, inhibits the growth of chloroquine-sensitive (D-6) and -resistant (W-2) clones of P. falciparum, with IC50s of 17 and 27 nM, respectively.

——

NSC5844 | NSC-5844 | NSC 5844 | RE640

PI3K/Akt/mTOR signaling

PI3K

CCR1

Cancer

——

140926-75-6

383.27

C20H16Cl2N4

>98% (HPLC)

In Vitro:?DMSO : 1 mg/mL (2.61 mM)

c1cc2c(ccnc2cc1Cl)NCCNc1c2ccc(cc2ncc1)Cl

N,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine

(-20℃)

With Ice Pack

≥ 2 years